Faculty
Jeffrey A Kahn
Contact
: Alpha Omega Alpha, 1990
The university of southern california psychosocial checklist: A novel tool to remotely screen transplant candidates with alcohol-associated liver disease prior to hospital transfer Liver Transpl. 2024 Sep 30. . View in PubMed
Unresectable Metastatic Solid Pseudopapillary Pancreatic Neoplasm Treated With Liver Transplantation ACG Case Rep J. 2024 Aug; 11(8):e01432. . View in PubMed
Characteristics and Outcomes Among US Commercially Insured Transgender Adults With Cirrhosis: A National Cohort Study Am J Gastroenterol. 2024 Jun 25. . View in PubMed
Low frequency of HBsAg reemergence in liver transplant recipients after stopping hepatitis B immune globulin: Implications for prophylaxis protocols Liver Transpl. 2024 Jun 01; 30(6):668-671. . View in PubMed
Benign to Malignant Hepatic Lesion Transformation in Abernethy Malformation ACG Case Rep J. 2024 Apr; 11(4):e01307. . View in PubMed
A retrospective analysis of rates of dermatology follow-up and new skin cancer diagnosis among solid organ transplant recipients during the COVID-19 pandemic JAAD Int. 2023 Mar; 10:53-54. . View in PubMed
Impact of Bacteria Types on the Clinical Outcomes of Spontaneous Bacterial Peritonitis Dig Dis Sci. 2023 05; 68(5):2140-2148. . View in PubMed
Living donor liver paired exchange between pediatric and adult recipients due to donor graft size mismatch Am J Transplant. 2023 03; 23(3):440-442. . View in PubMed
Clinical Significance of Ascitic Fluid Polymorphonuclear Leukocyte Percentage in Patients With Cirrhosis Without Spontaneous Bacterial Peritonitis Clin Transl Gastroenterol. 2023 09 01; 14(9):e00614. . View in PubMed
Addressing sex-based disparities in liver transplantation Curr Opin Organ Transplant. 2023 04 01; 28(2):110-116. . View in PubMed
Vaccination for coronavirus disease 2019 in liver transplantation candidates should be recommended but not mandated Clin Liver Dis (Hoboken). 2022 Nov; 20(5):154-156. . View in PubMed
A multicenter evaluation of hepatitis B reactivation with and without antiviral prophylaxis after kidney transplantation Transpl Infect Dis. 2022 Feb; 24(1):e13751. . View in PubMed
Treatment and outcomes of hepatocellular carcinoma in patients with Sickle cell disease: a population-based study in the US. HPB (Oxford). 2022 02; 24(2):234-243. . View in PubMed
Excess liver transplant waitlist mortality for patients with primary biliary cholangitis under MELD-Na allocation Clin Transplant. 2022 02; 36(2):e14527. . View in PubMed
Reply to: Comments on: Differential IgG4-Producing Plasma Cell Infiltration in Non- and Post-Transplant Plasma Cell Hepatitis Transpl Int. 2022; 35:10679. . View in PubMed
Differential IgG4-Producing Plasma Cell Infiltration in Non- and Post-Transplant Plasma Cell Hepatitis Transpl Int. 2022; 35:10182. . View in PubMed
A Programmatic Response, Including Bamlanivimab or Casirivimab-imdevimab Administration, Reduces Hospitalization and Death in COVID-19 Positive Abdominal Transplant Recipients Transplantation. 2022 02 01; 106(2):e153-e157. . View in PubMed
Transfusion-free Retransplantation for Post-liver Transplantation Hepatic Artery Thrombosis: How Much Augmentation Is Too Much? Transplant Direct. 2021 Nov; 7(11):e776.. View in PubMed
Autoimmune hepatitis triggered by COVID-19 Intern Med J. 2021 Jul; 51(7):1182-1183. . View in PubMed
Use of Hepatitis B Virus-Positive Organs in Organ Transplantation Clin Liver Dis. 2021 11; 25(4):841-857. . View in PubMed
We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver Diseases Hepatology. 2021 11; 74(5):2876-2887. . View in PubMed
A Healthy Liver After SVR: Food for Thought Dig Dis Sci. 2021 06; 66(6):1778-1779. . View in PubMed
IgG:IgM Ratios of Liver Plasma Cells Reveal Similar Phenotypes of Primary Biliary Cholangitis With and Without Features of Autoimmune Hepatitis Clin Gastroenterol Hepatol. 2021 02; 19(2):397-399. . View in PubMed
Impact of Morbid Obesity on Liver Transplant Candidacy and Outcomes: National and Regional Trends Transplantation. 2021 05 01; 105(5):1052-1060. . View in PubMed
Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures Eur J Gastroenterol Hepatol. 2021 04 01; 33(4):541-546. . View in PubMed
The use of organs from hepatitis C virus-viremic donors into uninfected recipients Curr Opin Organ Transplant. 2020 12; 25(6):620-625. . View in PubMed
Treatment and Outcomes of Early Stage Breast Cancer in Patients with Hepatic Dysfunction J Surg Res. 2020 12; 256:212-219. . View in PubMed
Liver transplantation as therapy for hepatocellular carcinoma Liver Int. 2020 02; 40 Suppl 1:116-121. . View in PubMed
Diagnosis of Focal Nodular Hyperplasia (FNH) after Liver Transplantation Case Rep Transplant. 2020; 2020:8824099. . View in PubMed
Comparison of Skin Cancer Incidence in Caucasian and Non-Caucasian Liver VsLung Transplant Recipients: A Tale of Two Regimens. Clin Drug Investig. 2019 Feb; 39(2):197-203. . View in PubMed
Assessment of Fibrosis in Liver Transplant Recipients: Diagnostic Performance of Shear Wave Elastography (SWE) and Correlation of SWE Findings With Biopsy Results AJR Am J Roentgenol. 2019 12; 213(6):W264-W271. . View in PubMed
Intentional Transmission of Hepatitis C With Organ Transplantation: With Opportunity Comes Responsibility Transplantation. 2019 11; 103(11):2215-2216. . View in PubMed
Hepatorenal Syndrome Clin J Am Soc Nephrol. 2019 05 07; 14(5):774-781. . View in PubMed
Reply Gastroenterology. 2017 07; 153(1):328-329. . View in PubMed
Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver TransplantationGastroenterology. 2017 02; 152(3):550-553. e8. . View in PubMed
Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation Transplant Direct. 2015 Jul; 1(6):e21. . View in PubMed
Imaging appearance in acute liver failure: correlation with clinical and pathology findings Dig Dis Sci. 2014 Aug; 59(8):1987-95. . View in PubMed
Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis CGastroenterology. 2010 Jun; 138(7):2321-312331. e1-2. . View in PubMed
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial Hepatology. 2006 Dec; 44(6):1675-84. . View in PubMed
Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial Am J Gastroenterol. 2006 May; 101(5):983-92. . View in PubMed
Live donor liver transplantation without blood products: strategies developed for Jehovah's Witnesses offer broad application Ann Surg. 2004 Aug; 240(2):350-7. . View in PubMed
Dr. Kahn’s primary research interests are in liver transplantation, hepatocellular carcinoma and viral hepatitis. He has written and co-authored several abstracts and peer-reviewed articles on various topics such as chronic hepatitis C and liver transplantation. He is also a distinguished lecturer.